Medically Reviewed Content
Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
Medicare coverage for GLP-1 medications has been one of the most debated healthcare topics in recent years. Millions of Medicare beneficiaries want access to medications like Ozempic, Wegovy, Mounjaro, and Zepbound, but coverage policies remain complex and often restrictive. Here is everything you need to know about Medicare GLP-1 coverage in 2026.
Does Medicare Cover Ozempic and Wegovy?
Medicare Part D plans may cover Ozempic when prescribed for type 2 diabetes, as it is FDA-approved for that indication. However, Wegovy, which is the same active ingredient (semaglutide) approved for weight management, has historically faced more limited coverage under Medicare. Recent legislative changes have begun to expand access, but coverage varies significantly by plan. Understanding GLP-1 insurance policies is essential for Medicare beneficiaries.
Medicare Part D GLP-1 Coverage Changes in 2026
The Inflation Reduction Act brought significant changes to Medicare drug pricing, including the $2,000 annual out-of-pocket cap that took effect in 2025. This cap applies to GLP-1 medications covered under Part D and can substantially reduce costs for beneficiaries who reach it. Additionally, ongoing legislative efforts have pushed for broader obesity medication coverage under Medicare, though the scope of these changes continues to evolve.
GLP-1 Medications Covered Under Medicare
As of 2026, the GLP-1 medications most commonly covered under Medicare Part D include those approved for type 2 diabetes: Ozempic (semaglutide), Trulicity (dulaglutide), Mounjaro (tirzepatide for T2D), and Rybelsus (oral semaglutide). Weight-loss specific versions like Wegovy and Zepbound face more variable coverage. Always verify your specific plan formulary, as different semaglutide brands carry different coverage profiles.
Take the Free Eligibility Quiz →
How to Get Medicare to Cover Your GLP-1 Medication
If your Medicare Part D plan does not initially cover your GLP-1 medication, several strategies can help. Ask your doctor to submit a prior authorization emphasizing the diabetes indication if applicable. Request a formulary exception with supporting clinical documentation. Compare plans during Open Enrollment to find one that covers your specific medication. For patients specifically seeking weight management, explore whether your plan covers the diabetes-approved version of the same medication.
Alternative Access for Medicare Patients
Medicare patients who cannot get coverage for GLP-1 medications have alternative options. Compounded semaglutide and tirzepatide through online telehealth GLP-1 programs offer cash-pay pricing that does not depend on insurance. Patient assistance programs from manufacturers may also provide discounts, though these are typically more limited for Medicare beneficiaries. Natural GLP-1 supplements represent another option for patients seeking more affordable alternatives.
Medicare Advantage vs Original Medicare for GLP-1 Coverage
Medicare Advantage plans (Part C) may offer different GLP-1 coverage than Original Medicare with a Part D plan. Some Advantage plans include more generous prescription drug benefits for weight-related medications. Compare both options during enrollment periods and check each plan’s formulary specifically for the GLP-1 medication you need.
Take the Free Eligibility Quiz →
Sources & References
- U.S. Food and Drug Administration (FDA) – Drug Approvals and Databases
- National Institutes of Health (NIH) – PubMed Medical Literature
- American Diabetes Association – Medication & Therapies
- Novo Nordisk – Clinical Research Data
- Eli Lilly – Medical Information
This content is regularly reviewed and updated to reflect the latest medical research and FDA guidance.